Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent HPV Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07256912
What this trial is testing

A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia

Who this might be right for
Vaccine EffectivenessHPV VaccinationSingle Dose+3 more
International Agency for Research on Cancer 1,266
Post-approval studies (Phase 4)Study completedNCT01544478
What this trial is testing

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Who this might be right for
Cervical CancerCervical Intraepithelial NeoplasiaAdenocarcinoma in Situ
Merck Sharp & Dohme LLC 1,030
Large-scale testing (Phase 3)Study completedNCT00090220
What this trial is testing

Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)

Who this might be right for
Healthy Adult Female ParticipantsPreventionPapillomavirus Infection+1 more
Merck Sharp & Dohme LLC 3,819
Not applicableEnded earlyNCT01355003
What this trial is testing

GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,080
Large-scale testing (Phase 3)Study completedNCT01461096
What this trial is testing

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 575
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Very early researchWithdrawnNCT00829608
What this trial is testing

Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis

Who this might be right for
Recurrent Respiratory Papillomatosis
University of Missouri-Columbia
Not applicableStudy completedNCT00727636
What this trial is testing

Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy

Who this might be right for
Inflammatory Bowel Disease
Boston Children's Hospital 53
Early research (Phase 1)Study completedNCT00635830
What this trial is testing

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 40
Post-approval studies (Phase 4)Study completedNCT02968420
What this trial is testing

Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine

Who this might be right for
Human Papillomavirus
University of British Columbia 18
Not applicableStudy completedNCT01702337
What this trial is testing

Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06632912
What this trial is testing

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Who this might be right for
Human Papillomavirus (HPV) InfectionHPV (Human Papillomavirus)-Associated Carcinoma
National Vaccine and Serum Institute, China 1,800
Large-scale testing (Phase 3)Ended earlyNCT05584332
What this trial is testing

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerGenital WartCIN1+9 more
Shanghai Bovax Biotechnology Co., Ltd. 3,131
Large-scale testing (Phase 3)Looking for participantsNCT05027776
What this trial is testing

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 1,348
Large-scale testing (Phase 3)Study completedNCT02263703
What this trial is testing

Immunogenicity of HPV Vaccine in Immunosuppressed Children

Who this might be right for
Autoimmune DiseaseJuvenile Idiopathic ArthritisInflammatory Bowel Disease+3 more
The University of New South Wales 55
Testing effectiveness (Phase 2)Study completedNCT00365716
What this trial is testing

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Who this might be right for
Papillomavirus InfectionsGenital Diseases, Female
Merck Sharp & Dohme LLC 1,158
Not applicableStudy completedNCT02276521
What this trial is testing

Evaluation of Long Term Immunity Following HPV Vaccination

Who this might be right for
Cervical CancerAnogenital Warts
Murdoch Childrens Research Institute 200
Not applicableStudy completedNCT00786409
What this trial is testing

Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women

Who this might be right for
Systemic Lupus Erythematosus
University of Chicago 27
Large-scale testing (Phase 3)Study completedNCT00496626
What this trial is testing

An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 600
Post-approval studies (Phase 4)Study completedNCT00911521
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study

Who this might be right for
Systemic Lupus Erythematosus
Tuen Mun Hospital 100
Next Page